IP Library › Granted Patent US 8,680,275
Granted Patent B2
US 8,680,275 · App. 13/503,312 · Granted Mar 25, 2014

Fused heterocyclic compounds as orexin receptor modulators

Inventors: Bryan James Branstetter (Oceanside, CA); Michael A. Letavic (San Diego, CA); Kiev S. Ly (San Diego, CA); Dale A. Rudolph (San Diego, CA); Brad M. Savall (San Diego, CA); Chandravadan R. Shah (San Diego, CA); Brock T. Shireman (Poway, CA)
Assignee: Janssen Pharmaceutica NV
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,680,275
App. No.
13/503,312
Granted
Mar 25, 2014
Kind
B2
Abstract

Disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo[3.2.0]heptane compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

Claims (327)

1. A chemical entity that is a compound of Formula (I):

wherein:

n is 0-1;

R 1 is a member selected from the group consisting of:

A) phenyl substituted or unsubstituted with one or two R a members, and substituted in the ortho position with R b ;

R a is independently selected from the group consisting of: halo, —C 1-4 alkyl, and —C 1-4 alkoxy, wherein two adjacent R a members may come together to form a six membered aromatic ring;

R b is a member selected from the group consisting of:

a) halo, —C 1-4 alkoxy, —CF 3 , or —CF 2 CHF 2 ;

b) 5-membered heteroaryl ring containing one oxygen or one sulfur members;

c) 5-6 membered heteroaryl ring containing one to three nitrogen members, optionally containing one oxygen member, substituted or unsubstituted with halo, —C 1-4 alkyl, tetrahydropyran-2-yl, or —N(CH 3 ) 2 ; and

d) phenyl substituted or unsubstituted with —F, or —CH 3 ;

B) pyridine substituted or unsubstituted with one or two R c members and substituted with R d , wherein R d is positioned adjacent to the point of attachment by R 1 ;

R c is a member independently selected from the group consisting of: —C 1-4 -alkyl, —CF 3 , and —C 1-4 alkoxy;

R d is a member selected from the group consisting of:

a) 5-6 membered heteroaryl ring selected from the group consisting of: 1H-1,2,3-triazol-1-yl, 2H-1,2,3-triazol-2-yl, 1H-pyrazol-3-yl, and 6-methyl-pyridin-2-yl; and

b) —CF 3 , —Br, or —C 1-4 alkoxy;

C) 6-membered heteroaryl ring selected from the group consisting of: pyrimidin-yl or pyrazin-yl, substituted or unsubstituted with a member independently selected from —CH 3 , —OCH 3 , or phenyl;

D) 5-membered heteroaryl ring selected from the group consisting of: 2-methyl-1,3-thiazol-yl, 5-methyl-isoxazol-4-yl, 2H-pyrazol-3-yl, 1H-pyrazol-4-yl, isoxazolyl, and 1,3-oxazol-4-yl, each substituted with phenyl substituted or unsubstituted with —F or —Cl; and

E) 3-methylfuran-2-yl, 9H-fluorene, 9H-fluoren-9-one, 3,5′-biisoxazole, [3-methyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)isoxazol-4-yl], or naphthyridine;

R 2 is a member selected from the group consisting of:

A) 6-membered heteroaryl ring containing two nitrogen members substituted or unsubstituted with one or more members independently selected from the group consisting of: halo, —C 1-4 alkyl, —C 1-4 alkoxy, —CF 3 , —NH 2 , —NHCH 3 , —N(C 1-4 -alkyl) 1-2 , —NHcyclopropyl, and phenyl;

B) pyridine substituted or unsubstituted with one or two members independently selected from the group consisting of: —C 1-4 alkyl, —N(C 1-4 alkyl) 2 , and —CF 3 ; and

C) quinoxalin-2-yl, benzooxazol-2-yl, or 5-chloro-1,3-benzoxazole;

and pharmaceutically acceptable salts of compounds of Formula (I).

2. A chemical entity defined in claim 1 , wherein n is 0.

3. A chemical entity defined in claim 1 , wherein n is 1.

4. A chemical entity defined in claim 1 , wherein R 1 is phenyl, where R a is a member selected from the group consisting of —F, —OCH 3 , and —CH 3 .

5. A chemical entity defined in claim 1 , wherein R b is a member selected from the group consisting of —Br, —I, —OCH 3 , —CF 2 CHF 2 and —CF 3 .

6. A chemical entity defined in claim 1 , wherein R b is a member selected from the group consisting of 2-pyrrol-1-yl, pyridin-2-yl, 3-chloropyridin-2-yl, 3-fluoropyridin-2-yl, 3-methylpyridin-2-yl, 4-methylpyridin-2-yl, 5-methylpyridin-2-yl, 6-methylpyridin-2-yl, pyridin-3-yl, N,N-dimethylpyridin-2-amine, pyrimidin-2-yl, pyrimidin-5-yl, 2H-1,2,3-triazol-2-yl, 1H-1,2,3-triazol-1-yl, 1H-1,2,4-triazol-5-yl, 1H-pyrazol-1-yl, 1H-pyrazol-3-yl, 1-methyl-1H-pyrazol-3-yl, 1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl, 1H-pyrazol-5-yl, 3-methyl-1,2,4-oxadiazol-5-yl, oxazol-2-yl, 2-thiophen-2-yl and 2-furan-2-yl.

7. A chemical entity defined in claim 1 , wherein R b is a member selected from the group consisting of phenyl, 3-fluorophenyl or 4-methylphenyl.

8. A chemical entity defined in claim 1 , wherein R 1 is pyridine, where R c is a member independently selected from the group consisting of —CH 3 , —OCH 3 , and —CF 3 , and R d is a member selected from the group consisting of —Br, —OCH 2 CH 2 CH 3 , —CF 3 , 1H-1,2,3-triazol-1-yl, 2H-1,2,3-triazol-2-yl, and 3-methylpyridin-2-yl.

9. A chemical entity defined in claim 1 , wherein R 1 is 2-ethoxy-naphthalen-1-yl, 4-phenyl-pyrimidin-2-yl, 5-(2-fluorophenyl)-2-methyl-1,3-thiazol-4-yl, 2-phenyl-2H-pyrazol-3-yl, 5-phenyl-isoxazol-4-yl, 5-methoxy-2-methylpyrimidin-4-yl, 3-phenylpyrazin-2-yl, 5-phenyl-1H-pyrazol-4-yl, 5-methyl-3-phenylisoxazol-4-yl, 5-phenylisoxazol-4-yl, 5-(2-fluorophenyl)-1,3-oxazol-4-yl, 5-(3-chlorophenyl)-1,3-oxazol-4-yl, 3′,5-dimethyl-3,5′-biisoxazole, 3-methyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)isoxazol-4-yl, 5-methyl-3-phenylisoxazol-4-yl, and 3-methylfuran-2-yl.

10. A chemical entity defined in claim 1 , wherein R 1 phenyl and R b is a member selected from the group consisting of pyrimidin-2-yl, 2H-1,2,3-triazol-2-yl, 1H-pyrazol-3-yl, and 2-thiophen-2-yl.

11. A chemical entity defined in claim 1 , wherein R 1 is 2-(2H-1,2,3-triazol-2-yl)phenyl, 2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl, 3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl, 4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl, 5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl, 3-fluoro-2-(1H-pyrazol-3-yl)phenyl, 5-fluoro-2-(1-methyl-1H-pyrazol-3-yl, or 2-thiophen-2-yl-phenyl.

12. A chemical entity defined in claim 1 , wherein R 2 is pyrimidine, pyrazine or pyridazine substituted or unsubstituted with one or more members independently selected from the group consisting of —C 1-4 alkyl, —OCH 3 , —CF 3 , —Cl, —N(CH 3 ) 2 , —NH 2 , —NHCH 3 , and phenyl.

13. A chemical entity defined in claim 1 , wherein R 2 is 2-dimethylamino-6-methyl-pyrimidin-4-yl, 2-dimethylamino-6-trifluoromethyl-pyrimidin-4-yl, 2-fluoro-6-pyrimidin-2-yl-phenyl, 2-methylpyrimidin-4-amine, 2-phenylpyrimidin-4-yl, 4,6-dimethoxypyrimidin-2-yl, 4,6-dimethylpyrimidin-2-yl, 4-methoxypyrimidin-2-yl, 4-methylpyrimidin-2-yl, 4-(trifluoromethyl)pyrimidin-2-yl, 4-phenylpyrimidin-2-yl, 5-(trifluoromethyl)pyrimidin-2-yl, 6-methyl-2-trifluoromethyl-pyrimidin-4-yl, 6-methylpyrimidin-4-yl, 6-methylpyrimidin-2-amine, N,6-dimethylpyrimidin-2-amine, N,N-dimethylpyrimidin-4-amine, N-cyclopropyl-pyrimidin-4-amine, N-methylpyrimidin-4-amine, pyrimidine-2,4-diamine, 3,6-dimethylpyrazin-2-yl, 3-methylpyrazin-2-yl, 5-methylpyrazin-2-yl, 5,6-dimethylpyrazin-2-yl, 6-methylpyrazin-2-yl, or 6-chloropyridazin-4-yl.

14. A chemical entity defined in claim 1 , wherein R 2 is pyridine substituted or unsubstituted with one or more members independently selected from the group consisting of —CH 3 , —CF 3 , and —N(CH 3 ) 2 .

15. A chemical entity defined in claim 1 , wherein R 2 is 4-methylpyridin-2-yl, 4-(trifluoromethyl)pyridin-2-yl, 4,6-dimethylpyridin-2-yl, 5-(trifluoromethyl)pyridin-2-yl, 5-methylpyridin-2-yl, 6-methylpyridin-2-yl, 6-(trifluoromethyl)pyridin-2-yl, or N,N-dimethylpyridin-4-amine.

16. A chemical entity defined in claim 1 , wherein R 2 is 2-dimethylamino-6-trifluoromethyl-pyrimidin-4-yl, 4,6-dimethylpyrimidin-2-yl, or 4-(trifluoromethyl)pyrimidin-2-yl.

17. A chemical entity defined in claim 1 , wherein R 1 is 2-(2H-1,2,3-triazol-2-yl)phenyl, 2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl, 3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl, 4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl, 5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl, 5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl, 3-fluoro-2-(1H-pyrazol-3-yl)phenyl, 5-fluoro-2-(1-methyl-1H-pyrazol-3-yl, or 2-thiophen-2-yl-phenyl and R 2 is 2-dimethylamino-6-trifluoromethyl-pyrimidin-4-yl, 4,6-dimethylpyrimidin-2-yl, or 4-(trifluoromethyl)pyrimidin-2-yl.

18. A chemical entity selected from the group consisting of:

(1R,6S) [8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-thiophen-2-yl-phenyl)-methanone;

(1R,6S) [8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-furan-2-yl-phenyl)-methanone;

(1R,6S)-Biphenyl-2-yl-[8-(4,6-dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)(8-Quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-(2-thiophen-2-yl-phenyl)-methanone;

(1R,6S)Biphenyl-2-yl-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1R,6S)(2-Furan-2-yl-phenyl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1R,6S)[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-pyrrol-1-yl-phenyl)-methanone;

Biphenyl-2-yl-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

Biphenyl-2-yl-[8-(4-phenyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)(4′-Methyl-biphenyl-2-yl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(8-Benzooxazol-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-biphenyl-2-yl-methanone;

(2,6-Dimethoxy-phenyl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1R,6S)(2-Bromo-phenyl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1R,6S)(2-Pyridin-3-yl-phenyl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(2,6-Dimethoxy-phenyl)-[8-(4-phenyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(8-Benzooxazol-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-(2,6-dimethoxy-phenyl)-methanone;

(1S,6R)Biphenyl-2-yl-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1S,6R)Biphenyl-2-yl-[8-(4,6-dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone;

(1R,6S)[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone;

(1R,6S)[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-ethoxy-naphthalen-1-yl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-pyrimidin-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(4-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(3,6-Dimethyl-pyrazin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(4-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-(2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[8-(6-methyl-2-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)(5-Fluoro-2-pyrimidin-2-yl-phenyl)-(8-quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-methanone;

(1R,6S)-(4-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[8-(6-methyl-2-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)-[8-(6-Methyl-2-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(4-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-(8-Quinoxalin-2-yl-3,8-diaza-bicyclo[4.2.0]oct-3-yl)-(2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-methyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-(5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[8-(6-methyl-2-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-methyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-methyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-methyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(4-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(1R,6S)-[8-(2-Dimethylamino-6-trifluoromethyl-pyrimidin-4-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

3-(Biphenyl-2-ylcarbonyl)-6-(4-phenylpyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

2-[3-(Biphenyl-2-ylcarbonyl)-3,6-diazabicyclo[3.2.0]hept-6-yl]quinoxaline;

2-{3-[(2-Thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]hept-6-yl}quinoxaline;

6-(4-Phenylpyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

2-(3-{[5-(2-Fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}-3,6-diazabicyclo[3.2.0]hept-6-yl)quinoxaline;

3-{[5-(2-Fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}-6-(4-phenylpyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

3-[(2-Methoxyphenyl)carbonyl]-6-(4-phenylpyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

2-{3-[(2-Methoxyphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]hept-6-yl}quinoxaline;

6-(4-Phenylpyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

6-(4-Phenylpyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethylpyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

3-[(2-Bromophenyl)carbonyl]-6-(4,6-dimethylpyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

(2-Bromo-phenyl)-[6-(4-methyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-methanone;

6-(4-Methylpyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

3-(Biphenyl-2-ylcarbonyl)-6-(4-methylpyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

6-(4-Methoxypyrimidin-2-yl)-3-[(2-thiophen-2-ylphenyl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

3-(Biphenyl-2-ylcarbonyl)-6-(4-methoxypyrimidin-2-yl)-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethoxypyrimidin-2-yl)-3-[(2-ethoxynaphthalen-1-yl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethylpyrimidin-2-yl)-3-[(2-ethoxynaphthalen-1-yl)carbonyl]-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethylpyrimidin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,6-diazabicyclo[3.2.0]heptane;

6-(4-Phenylpyrimidin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,6-diazabicyclo[3.2.0]heptane;

6-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,6-diazabicyclo[3.2.0]heptane;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(3-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[8-(6-methyl-pyridin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-methanone;

[8-(4,6-Dimethoxy-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(2-phenyl-2H-pyrazol-3-yl)-methanone;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(5-phenyl-isoxazol-4-yl)-methanone;

[6-(4,6-Dimethyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(4,6-Dimethyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(3-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(4,6-Dimethyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(4,6-Dimethyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(4-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(3,6-Dimethyl-pyrazin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(3,6-Dimethyl-pyrazin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(3-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

[6-(4,6-Dimethoxy-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-(3-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone;

(3-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[6-(4-methyl-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-methanone;

(3-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[6-(4-methoxy-pyrimidin-2-yl)-3,6-diaza-bicyclo[3.2.0]hept-3-yl]-methanone;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(3′-fluoro-biphenyl-2-yl)-methanone;

[8-(4,6-Dimethyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]oct-3-yl]-(4′-methyl-biphenyl-2-yl)-methanone;

(1R,6S)-8-(6-Chloropyridazin-4-yl)-3-{[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[6-methyl-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[2-(trifluoromethyl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[6-Methyl-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-8-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-[(2-Fluoro-6-pyrimidin-2-ylphenyl)carbonyl]-8-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[6-Methyl-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-8-[4-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(3,6-Dimethylpyrazin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(3,6-Dimethylpyrazin-2-yl)-3-{[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(3,6-Dimethylpyrazin-2-yl)-3-{[2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(3,6-Dimethylpyrazin-2-yl)-3-{[3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(5-Methylpyrazin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(5-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(5-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(5-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(5-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(3-Methylpyrazin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(3-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(3-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(3-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(3-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(6-Methylpyrazin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

2-[(1R,6S)-3-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]quinoxaline;

2-[(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]quinoxaline;

2-[(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]quinoxaline;

2-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]quinoxaline;

5-Chloro-2-[(1R,6S)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-1,3-benzoxazole;

5-Chloro-2-[(1R,6S)-3-{[2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-1,3-benzoxazole;

5-Chloro-2-[(1R,6S)-3-{[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-1,3-benzoxazole;

5-Chloro-2-[(1R,6S)-3-{[4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-1,3-benzoxazole;

5-Chloro-2-[(1R,6S)-3-{[3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-1,3-benzoxazole;

(1R,6S)-3-{[2-Fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyridin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(6-Methylpyridin-2-yl)-3-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyridin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(4-methylpyridin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyridin-2-yl)-3-{[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[6-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(5-methylpyridin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

4-{[(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]oct-3-yl]carbonyl}-1,8-naphthyridine;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-methyl-2-(1H-pyrazol-1-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(5-methoxy-2-methylpyrimidin-4-yl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(3-phenylpyrazin-2-yl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-methyl-2-(1H-1,2,3-triazol-1-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(4-methylpyridin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-Methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

N,N-Dimethyl-2-[(1R,6S)-3-{[3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]pyridin-4-amine;

2-[(1R,6S)-3-{[4-Methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N,N-dimethylpyridin-4-amine;

2-{(1R,6S)-3-[(3-Fluoro-2-pyrimidin-2-ylphenyl)carbonyl]-3,8-diazabicyclo[4.2.0]oct-8-yl}-N,N-dimethylpyridin-4-amine;

2-[(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N,N-dimethylpyridin-4-amine;

(1R,6S)-3-{[3-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[4-Methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[3-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyridin-2-yl)-3-{[3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyridin-2-yl)-3-{[4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

2-[(1R,6S)-3-{[5-Methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N,N-dimethylpyridin-4-amine;

(1R,6S)-8-(4,6-Dimethylpyridin-2-yl)-3-{[5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-[(3-Fluoro-2-pyrimidin-2-ylphenyl)carbonyl]-8-[4-(trifluoromethyl)pyridin-2-yl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyridin-2-yl)-3-[(3-fluoro-2-pyrimidin-2-ylphenyl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-[(6-Bromo-2-fluoro-3-methoxyphenyl)carbonyl]-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-fluoro-2-(1H-pyrazol-1-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(2-fluoro-3-methoxy-6-pyrimidin-2-ylphenyl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5,6-dimethyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5,6-dimethyl-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[2-(1H-1,2,3-triazol-1-yl)-6-(trifluoromethyl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-methyl-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[6-methoxy-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[6-methoxy-2-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-[(2-Bromo-5-fluorophenyl)carbonyl]-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(5-fluoro-2-pyrimidin-5-ylphenyl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

5-(2-{[(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]oct-3-yl]carbonyl}-4-fluorophenyl)-N,N-dimethylpyridin-2-amine;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-(9H-fluoren-4-ylcarbonyl)-3,8-diazabicyclo[4.2.0]octane;

4-{[(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]oct-3-yl]carbonyl}-9H-fluoren-9-one;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-({5-fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]phenyl}carbonyl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-fluoro-2-(1H-pyrazol-5-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[2-(1H-1,2,4-triazol-5-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-(4-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(5-phenyl-1H-pyrazol-4-yl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(5-phenylisoxazol-4-yl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-(2-fluorophenyl)-1,3-oxazol-4-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-{[5-(3-Chlorophenyl)-1,3-oxazol-4-yl]carbonyl}-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

4′-{[(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]oct-3-yl]carbonyl}-3′,5-dimethyl-3,5′-biisoxazole;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-methyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)isoxazol-4-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-3-[(3-Bromopyridin-2-yl)carbonyl]-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-(1H-1,2,3-triazol-1-yl)pyridin-2-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[3-fluoro-2-(1H-pyrazol-3-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-[(3-fluoro-2-pyrimidin-2-ylphenyl)carbonyl]-3,8-diazabicyclo[4.2.0]octane;

4-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-6-methylpyrimidin-2-amine;

4-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N,6-dimethylpyrimidin-2-amine;

(1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3-{[5-fluoro-2-(1-methyl-1H-pyrazol-3-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane;

6-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N,N-dimethylpyrimidin-4-amine;

6-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-N-methylpyrimidin-4-amine;

6-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]-2-methylpyrimidin-4-amine;

6-[(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]pyrimidine-2,4-diamine;

(1R,6S)-3-{[5-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-8-(6-methylpyrimidin-4-yl)-3,8-diazabicyclo[4.2.0]octane;

N-Cyclopropyl-6-[(1R,6S)-3-{[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]oct-8-yl]pyrimidin-4-amine;

(5-methyl-2-(trifluoromethyl)phenyl)((1R,6S)-8-(2-phenylpyrimidin-4-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(2-phenylpyrimidin-4-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(2-(1,1,2,2-tetrafluoroethoxy)phenyl)methanone;

(5-methyl-3-phenylisoxazol-4-yl)((1R,6S)-8-(2-phenylpyrimidin-4-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(5,6-Dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(5,6-Dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

(2-(2H-1,2,3-triazol-2-yl)phenyl)((1R,6S)-8-(5,6-dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(5,6-dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(5,6-dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(5,6-dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(5,6-dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-propoxypyridin-2-yl)methanone;

(3-propoxypyridin-2-yl)((1R,6S)-8-(5-(trifluoromethyl)pyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3-propoxypyridin-2-yl)((1R,6S)-8-(5-(trifluoromethyl)pyridin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3-Propoxypyridin-2-yl)((1R,6S)-8-(quinoxalin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(2,6-dimethoxyphenyl)((1R,6S)-8-(quinoxalin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(2,6-Dimethoxyphenyl)((1R,6S)-8-(5-(trifluoromethyl)pyridin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(2,6-Dimethoxyphenyl)((1R,6S)-8-(5-(trifluoromethyl)pyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(2,6-Dimethoxyphenyl)((1R,6S)-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-methylfuran-2-yl)methanone;

(3-Methylfuran-2-yl)((1R,6S)-8-(5-(trifluoromethyl)pyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3-Methylfuran-2-yl)((1R,6S)-8-(5-(trifluoromethyl)pyridin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3-Methylfuran-2-yl)((1R,6S)-8-(quinoxalin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3,6′-Dimethyl-[2,3′-bipyridin]-2′-yl)((1R,6S)-8-(quinoxalin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3,6′-Dimethyl-[2,3′-bipyridin]-2′-yl)((1R,6S)-8-(5-(trifluoromethyl)pyridin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3,6′-Dimethyl-[2,3′-bipyridin]-2′-yl)((1R,6S)-8-(5-(trifluoromethyl)pyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

(3,6′-Dimethyl-[2,3′-bipyridin]-2′-yl)((1R,6S)-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(5,6-Dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(5,6-Dimethylpyrazin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-iodophenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(oxazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(pyridin-2-yl)phenyl)methanone;

(2-(3-Chloropyridin-2-yl)-3-fluorophenyl)((1R,6S)-8-(4,6-dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(3-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(5-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(5-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(pyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(5-fluoro-2-(oxazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(5-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(pyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(oxazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(pyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(oxazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(6-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(pyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(4-fluoro-2-(oxazol-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(6-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(4-methylpyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(3-fluoropyridin-2-yl)phenyl)methanone;

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(pyridin-2-yl)phenyl)methanone;

(1R,6S)-3-{[2-(2H-1,2,3-Triazol-2-yl)phenyl]carbonyl}-8-(4,5,6-trimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octane; and

((1R,6S)-8-(4,6-Dimethylpyrimidin-2-yl)-3,8-diazabicyclo[4.2.0]octan-3-yl)(3-fluoro-2-(oxazol-2-yl)phenyl)methanone.

19. A pharmaceutical composition for treating a disease, disorder or medical condition mediated by orexin activity comprising:

(a) an effective amount of at least one chemical entity selected from compounds of Formula (I):

wherein:

n is 0-1;

R 1 is a member selected from the group consisting of:

A) phenyl substituted or unsubstituted with one or two R a members, and substituted in the ortho position with R b ;

R a is independently selected from the group consisting of: halo, —C 1-4 alkyl, and —C 1-4 alkoxy, wherein two adjacent R a members may come together to form a six membered aromatic ring;

R b is a member selected from the group consisting of:

a) halo, —C 1-4 alkoxy, —CF 3 , or —CF 2 CHF 2 ;

b) 5-membered heteroaryl ring containing one oxygen or one sulfur members;

c) 5-6 membered heteroaryl ring containing one to three nitrogen members, optionally containing one oxygen member, substituted or unsubstituted with halo, —C 1-4 alkyl, tetrahydropyran-2-yl, or —N(CH 3 ) 2 ; and

d) phenyl substituted or unsubstituted with —F, or —CH 3 ;

B) pyridine substituted or unsubstituted with one or two R c members and substituted with R d , wherein R d is positioned adjacent to the point of attachment by R 1 ;

R c is a member independently selected from the group consisting of: —C 1-4 -alkyl, —CF 3 , and —C 1-4 alkoxy,

R d is a member selected from the group consisting of:

a) 5-6 membered heteroaryl ring selected from the group consisting of: 1H-1,2,3-triazol-1-yl, 2H-1,2,3-triazol-2-yl, 1H-pyrazol-3-yl, and 6-methyl-pyridin-2-yl; and

b) —CF 3 , —Br, or —C 1-4 alkoxy;

C) 6-membered heteroaryl ring selected from the group consisting of: pyrimidin-yl and pyrazin-yl, substituted or unsubstituted with a member independently selected from —CH 3 , —OCH 3 , or phenyl;

D) 5-membered heteroaryl ring selected from the group consisting of: 2-methyl-1,3-thiazol-yl, 5-methyl-isoxazol-4-yl, 2H-pyrazol-3-yl, 1H-pyrazol-4-yl, isoxazolyl, and 1,3-oxazol-4-yl, each substituted with phenyl substituted or unsubstituted with —F or —Cl; and

E) 3-methylfuran-2-yl, 9H-fluorene, 9H-fluoren-9-one, 3,5′-biisoxazole, [3-methyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)isoxazol-4-yl], or naphthyridine;

R 2 is a member selected from the group consisting of:

A) 6-membered heteroaryl ring containing two nitrogen members substituted or unsubstituted with one or more members independently selected from the group consisting of: halo, —C 1-4 alkyl, —C 1-4 alkoxy, —CF 3 , —NH 2 , —NHCH 3 , —N(C 1-4 alkyl) 1-2 , —NHcyclopropyl, and phenyl;

B) pyridine substituted or unsubstituted with one or two members independently selected from the group consisting of: —C 1-4 alkyl, —N(C 1-4 alkyl) 2 , and —CF 3 ; and

C) quinoxalin-2-yl, benzooxazol-2-yl, or 5-chloro-1,3-benzoxazole;

and pharmaceutically acceptable salts of compounds of Formula (I); and

(b) at least one pharmaceutically acceptable excipient.

20. A pharmaceutical composition comprising and effective amount of at least one chemical entity of claim 18 , and at least one pharmaceutically acceptable excipient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2012
From: BRANSTETTER, BRYAN J.; LETAVIC, MICHAEL A.; LY, KIEV S.; RUDOLPH, DALE S.; SAVALL, BRAD M.; SHAH, CHANDRAVANDAN R.; SHIREMAN, BROCK T.
To: JANSSEN RESEARCH NV
Reel/Frame 028092/0468 →
Continuity (2)
Provisional Application 61254529 · Oct 23, 2009
Related Publication 20120202783A1 · Aug 9, 2012